Dialyzer Reaction (First-Use Syndrome)

Dialyzer reactions are adverse reactions that occur during hemodialysis (HD) in response to the dialyzer membrane or residual sterilants. They were historically called "first-use syndrome" because they often occurred on first exposure to a particular dialyzer. They are now rare due to improved biocompatible membranes and safer sterilization methods.

Classification: Type A vs. Type B

Feature	Type A (Anaphylactic)	Type B (Non-specific)
Onset	Within 5-20 min (sometimes as early as 1-10 min)	20-40 min into dialysis session
Mechanism	IgE-mediated anaphylaxis; or bradykinin excess (ACE inhibitors + AN69 membrane)	Complement activation (alternate pathway)
Cause	Ethylene oxide (ETO) sterilant, formaldehyde, polysulfone membrane; AN69 membrane + ACEi	Cuprophane or polysulfone/polyethersulfone membranes activating complement
Severity	Severe - potentially life-threatening	Mild-moderate; usually self-limiting
Symptoms	Pruritus, urticaria, angioedema, bronchospasm, laryngeal edema, dyspnea, chest/back pain, vomiting, hypotension, cardiac arrest, "sense of impending doom"	Chest pain, back pain, nausea, vomiting; symptoms typically settle within 1 hour

Type A - Pathophysiology

IgE-mediated hypersensitivity to membrane material (e.g., polysulfone) or to sterilizing agents (ethylene oxide, formaldehyde)
Bradykinin accumulation: The AN69 (polyacrylonitrile) membrane generates bradykinin. In patients on ACE inhibitors (which block bradykinin degradation), this leads to severe hypotension and anaphylactoid reactions. This is a special and well-recognized cause.
Bacterial peptide contamination of dialysate can also trigger Type A reactions

Type B - Pathophysiology

Complement activation via the alternate pathway, triggered by free hydroxyl groups on membranes (especially cuprophane, older cellulose membranes)
Leads to neutrophil activation and pulmonary leukocyte sequestration
Results in relatively mild chest/back discomfort

Management

Type A - STOP DIALYSIS IMMEDIATELY

Do NOT return blood from the circuit to the patient (the offending substance is in the circuit)
Clamp blood lines and discard the circuit
Administer epinephrine (for anaphylaxis), corticosteroids, antihistamines as indicated
IV fluids for hypotension
Supplemental oxygen; airway support if needed
For ACEi + AN69 reactions: discontinue ACE inhibitor or switch dialyzer

Type B - Can usually continue dialysis

Symptomatic management (oxygen, reassurance)
Symptoms typically resolve within 1 hour without stopping dialysis
Investigate for hemolysis (rule out as alternative cause)

Prevention

Switch to biocompatible synthetic membranes (polysulfone, polyacrylonitrile) - cause less complement activation than older cellulose/cuprophane membranes
Avoid ethylene oxide sterilization - use steam, gamma irradiation, or electron beam sterilization instead
Thoroughly rinse/prime the dialyzer with saline (500 mL flush before use, recirculate at 300-400 mL/min, then flush again) before connecting to the patient
Avoid AN69 membrane in patients on ACE inhibitors - switch to a different membrane type or stop ACEi
Dialyzer reuse (when practiced): paradoxically reduces first-use reactions since residual sterilants are washed out

Key Notes

Type A can be remembered as "Anaphylactic"; Type B as "Back pain / Boring" (less severe)
ACEi + AN69 membrane is a classic exam combination causing severe bradykinin-mediated reaction
Modern dialysis rarely sees these reactions due to improved biocompatible membranes and ETO-free sterilization
Historical cuprophane membranes were the main culprit for Type B; largely replaced now

Sources: - Brenner and Rector's The Kidney (9780323532655), p. 2750 | AJKD Hemodialysis Emergencies Core Curriculum 2021 | BC Renal Provincial Guideline (Updated Mar 2025)

This is a shared conversation. Sign in to Orris to start your own chat.